Max Eberle

Max Eberle is a Principal Scientist and Lab Head at AbbVie, where they focus on analytical development of biologics. They have previously held positions at the Max-Planck-Institute for Biophysics in molecular neurogenetics and the University of South Florida's Byrd Alzheimer's Institute, contributing to significant research in neuronal regeneration and in-vivo cell migration assays. Max has a Doctorate in Pharmacy from Universitätsklinikum Frankfurt am Main and a Diplom in Biology from the Karlsruhe Institute of Technology. Their experience also includes internship roles at Merz Pharmaceuticals and School of Translational Medicine, as well as a research position developing a new therapy for Multiple Sclerosis.